Nitric oxide synthase inhibition and elevated endothelin increase oxygen consumption but do not affect glucose and palmitate oxidation in the isolated rat heart

Journal of Physiology and Pharmacology

Volumn 55, Issue 1 I, 2004, Pages 27-38

  Kurzelewski, M ^a   Duda, M ^a   Stanley, W C ^b   Beresewicz A ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelin; Energetics; Free fatty acids oxidation; Glucose oxidation; Isolated rat heart; Nitric oxide; Oxygen consumption

Indexed keywords

CARBON 14; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; FATTY ACID; GLUCOSE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PALMITIC ACID; TEZOSENTAN; TRITIUM;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; ENERGY TRANSFER; ENZYME INHIBITION; FATTY ACID OXIDATION; GLUCOSE OXIDATION; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART WORK; ISOLATED HEART; MALE; NONHUMAN; PROTEIN SECRETION; RAT;

ANIMALS; CORONARY CIRCULATION; DIASTOLE; ENDOTHELIN-1; GLUCOSE; HEART RATE; HEART VENTRICLES; LACTIC ACID; MALE; MYOCARDIUM; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; OXYGEN CONSUMPTION; PALMITATES; PYRIDINES; RATS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; TETRAZOLES; TRITIUM; WATER;

EID: 1942504123     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Bba-Lipid Lipid Metab 1994; 1213:263-276.
2. Stanley WC, Lopaschuk GD, Mccormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 1997; 34:25-33.
3. Stanley WC, Chandler MP. Energy metabolism in the normal and failing heart: potential for therapeuthic interventions. Heart Fail Rev 2002; 7:115-130.
4. Recchia FA. Role of nitric oxide in the regulation of substrate metabolism in heart failure. Heart Fail Rev 2002; 7:141-148.
5. Mjos OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 1971; 50:1386-1389.
6. Burkhoff D, Weiss RG, Schulman SP, Kalil-Filho R, Wannenburg T, Gerstenblith G. Influence of metabolic substrate on rat heart function and metabolism at different coronary flows. Am J Physiol Heart Circ Physiol 1991; 261:H741-H750.
7. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol 2000; 278:H1345-H1351.
8. Simonsen S, Kjekshus JK. The effect of free fatty acids on myocardial oxygen consumption during atrial pacing and catecholamine infusion in man. Circulation 1978; 58:484-491.
9. Pepine CJ, Wolff AA. A controlled trial with a novel ant-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Am J Cardiol 1999; 84:46-50.
10. Sabbah HN, Chandler MP, Mishima T, Suzuki G, Chaudhry P, Nass O et al. Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure. J Card Fail 2002; 8:416-422.
11. Taniguchi M, Wilson C, Hunter CA, Pehowich DJ, Clanachan AS, Lopaschuk GD. Dichloroacetate improves cardiac efficiency after ischemia independent of changes in mitochondtial proton leak. Am J Physiol Heart Circ Physiol 2001; 280:H1762-H1769.
12. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142.
13. Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res 1996; 79: 363-380.
14. Hare JM. Nitric oxide and excitation contraction coupling. J Mol Cell Cardiol 2003; 35: 719-729.
15. Bernstein RD, Ochoa FY, Xu XB, Forfia P, Shen WQ, Thompson CI et al. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res 1996; 79:840-848.
16. Suto N, Mikuniya A, Okubo T, Hanada H, Shinozaki N, Okumura KN. Nitric oxide modulates cardiac contractility and oxygen consumption without changing contractile efficiency. Am J Physiol 1998; 44:H41-H49.
17. Recchia FA, McConnel PI, Bernstein RD, Vogel TR, Xu X, Hintze TH. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart hailure in the conscious dog. Circ Res 1998; 83:969-979.
18. Recchia FA, Mcconnell PI, Loke KE, Xu XB, Ochoa M, Hintze TH. Nitric oxide controls cardiac substrate utilization in conscious dog. Cardiovasc Res 1999; 44:325-332.
19. Tada H, Thompson CI, Recchia FA, Loke KE, Ochoa M, Smith CJ et al. Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff mouse heart. Circ Res 2000; 86:270-274.
20. Depre C, Gaussin V, Ponchaut S, Fischer Y, Vanoverschelde JL, Hue L. Inhibition of myocardial glucose uptake by cGMP. Am J Physiol 1998; 43:H1443-H1449.
21. Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 1993; 268:25836-25845.
22. Kuo L, Davis MJ, Chilian WM. Longitudinal gradients for endothelium-dependent and -independent vascular responses in the coronary microcirculation. Circulation 1995; 92:518-525.
23. Jones CJH, Kuo L, Davis MJ, Chilian WM. Regulation of coronary blood flow: coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res 1995; 29: 585-596.
24. Wang QD, Gonon A, Shimizu M, Sjoquist PO, Pernow J. Contribution of endothelin to the coronary vasoconstriction in the isolated rat heart induced by nitric oxide synthase inhibition. Acta Physiol Scand 1998; 163:325-330.
25. Fink J, Fan NYT, Rosenfeld L, Stier CT. Contribution of endothelin to the acute pressor response of L-NAME in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 1998; 31:618-622.
26. Parent R, Lavallee M. Endothelin-dependent effects limit flow-induced dilation of conductance coronary vessels after blockade of nitric oxide formation in conscious dogs. Cardiovasc Res 2000; 45:470-477.
27. Brunner F, Leonhard B, Kukovetz WR, Mayer B. Role of endothelin, nitric oxide and 1-arginine release in ischaemia/reperfusion injury of rat heart. Cardiovasc Res 1997; 36:60-66.
28. Goodwin AT, Amrani M, Gray CC, Jayakumar J, Yacoub MH. Role of endogenous endothelin in the regulation of basal coronary tone in the rat. J Physiol 1998; 511:549-557.
29. Wenzel RR, Fleisch M, Shaw S, Noll G, Kaufmann U, Schmitt R et al. Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease. Circulation 1998; 98:2235-2240.
30. Kurzelewski M, Czarnowska E, Beresewicz A. Endothelin in the mechanism of endothelial injury and neutrophil adhesion in the post-ischemic guinea pig heart. Eur J Pharmacol 2002; 434:95-107.
31. Beresewicz A, Dobrzyn A, Gorski J. Accumulation of specific ceramides in ischemic/reperfused rat heart; Effect of ischemic preconditioning. J Physiol Pharmacol 2002; 53:371-382.
32. Gertz EW, Wisneski JA, Stanley WC, Neese RA. Myocardial substrate utilization during exercise in humans: Dual carbon-labeled carbohydrate isotope experiments. J Clin Invest 1988; 82:2017-2025.
33. Wisneski JA, Stanley WC, Neese RA, Gertz EW. Effects of acute hyperglycemia on myocardial glycolytic activity in humans. J Clin Invest 1990; 85:1648-1656.
34. Stadler J, Billiar TR, Curran D, Stuehr DJ, Ochoa JB, Simmons RL. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 1991; 260:C910-C916.
35. Adler S, Huang H, Loke KE, Xu X, Tada H, Laumas A et al. Endothelial nitric oxide synthase plays an essential role in regulation of renal oxygen consumption by NO. Am J Physiol 2001; 280:F838-F843.
36. Brown GC. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999; 1411: 351-369.
37. Depre C, Vanoverschelde JL, Goudemant JF, Mottet I, Hue L. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 1995; 92:1911-1918.
38. Recchia FA, Osorio JC, Chandler MP, Xu X, Panchal AR, Lopaschuk GD et al. Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs. Am J Physiol 2002; 282:E197-E206.
39. Takeuchi Y, Kihara Y, Inagaki K, Yoneda T, Sasayama S. Endothelin-1 has a unique oxygen-saving effect by increasing contractile efficiency in the isolated rat heart. Circulation 2001; 103:1557-1563.
40. Noguchi T, Chen Z, Bell SP, Nyland L, LeWinter MM, M.M. Endothelin receptor blockade has an oxygen-saving effect in Dahl salt-sensitive rats with heart failure. Am J Physiol 2003; 285:H1428-H1431.
41. max and oxygen consumption in blood-perfused rabbit heart: energetic consequences of Gregg's phenomenon. Circ Res 1991; 68:482-492.